Stop TB Partnership

TBVI receives US $3 million research grant from Gates Foundation

31 May 2012 - Lelystad, The Netherlands - The TuBerculosis Vaccine Initiative (TBVI), a non-profit organization that supports the development of new vaccines against tuberculosis (TB), will receive a new grant from the Bill & Melinda Gates Foundation. The US $3 million award will be spread over three years, allowing TBVI to support the development of several TB vaccine candidates.

"Wonderful progress has been made in the field of TB vaccine research over the past years. But we are not there yet," said TBVI director Jelle Thole. "Now more than ever, we need to keep investing to make sure we can guide some promising vaccine candidates through the consecutive stages of development. We’re grateful that the Gates Foundation decided to make this possible and continue their support to us."